Tumor hypoxia and expression of c-met in cervical cancer

Gynecologic Oncology

Volumn 104, Issue 1, 2007, Pages 181-185

  Leo, Cornelia ^a   Horn, Lars Christian ^a   Einenkel, Jens ^a   Hentschel, Bettina ^a   Höckel, Michael ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Cancer; Cervix; Gene regulation; Metastasis; Tumor hypoxia; Tumor microenvironment; Uterus

Indexed keywords

SCATTER FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CANCER GENETICS; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; ELECTRODE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; OVERALL SURVIVAL; OXYGEN TISSUE LEVEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTO ONCOGENE; TUMOR BIOPSY; TUMOR DIFFERENTIATION; TUMOR VOLUME; UTERINE CERVIX CANCER;

ADULT; AGED; BIOPSY; CELL HYPOXIA; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; OXYGEN; PARTIAL PRESSURE; RECEPTOR PROTEIN-TYROSINE KINASES; UTERINE CERVICAL NEOPLASMS;

EID: 33846008051     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.07.040     Document Type: Article

References (36)

1. Höckel M., Schlenger K., Aral B., Mitze M., Schäffer U., and Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 56 (1996) 4509-4515
2. Nordsmark M., Overgaard M., and Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother. Oncol. 41 (1996) 31-39
3. Brizel D.M., Scully S.P., Harrelson J.M., et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 56 (1996) 941-943
4. Harris A.L. Hypoxia-a key regulatory factor in tumour growth. Nat. Rev., Cancer 2 (2002) 38-47
5. Leo C., Giaccia A.J., and Denko N.C. The hypoxic tumor microenvironment and gene expression. Semin. Radiat. Oncol. 14 (2004) 207-214
6. Graeber T.G., Osmanian C., Jacks T., et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379 (1996) 88-91
7. Kim C.Y., Tsai M.H., Osmanian C., et al. Selection of human cervical epithelial cells that possess reduced apoptotic potential to low-oxygen conditions. Cancer Res. 57 (1997) 4200-4204
8. Bottaro D.P., Rubin J.S., Faletto D.L., et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251 (1991) 802-804
9. Naldini L., Vigna E., Narsimhan R.P., et al. Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET. Oncogene 6 (1991) 501-504
10. Birchmeier C., Birchmeier W., Gherardi E., and Vande Woude G.F. Met, metastasis, motility and more. Nat. Rev., Mol. Cell Biol. 4 (2003) 915-925
11. Jiang W.G., Martin T.A., Parr C., Davies G., Matsumoto K., and Nakamura T. Hepatocyte growth factor, its receptor, and their potential value in cancer therapies. Crit. Rev. Oncol./Hematol. 53 (2005) 35-69
12. Jeffers M., Rong S., and Vande Woude G.F. Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network. Mol. Cell. Biol. 16 (1996) 1115-1125
13. Shimabukuro K., Ichinose S., Koike R., et al. Hepatocyte growth factor/scatter factor is implicated in the mode of stromal invasion of uterine squamous cervical cancer. Gynecol. Oncol. 83 (2001) 205-215
14. Wong A.S., Leung P.C., and Auersperg N. Hepatocyte growth factor promotes in vitro scattering and morphogenesis of human cervical carcinoma cells. Gynecol. Oncol. 78 (2000) 158-165
15. Takeuchi H., Bilchik A., Saha S., et al. c-MET expression level in primary colon cancer: a predictor of tumor invasion and lymph node metastases. Clin. Cancer Res. 9 (2003) 1480-1488
16. Baykal C., Ayhan A., Al A., Yuce K., and Ayhan A. Overexpression of the c-Met/HGF receptor and its prognostic significance in uterine cervix carcinomas. Gynecol. Oncol. 88 (2003) 123-129
17. Lengyel E., Prechtel D., Resau J.H., et al. C-Met overexpression in node-positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu. Int. J. Cancer 113 (2005) 678-682
18. Qian C.N., Guo X., Cao B., et al. Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma. Cancer Res. 62 (2002) 589-596
19. Pennacchietti S., Michieli P., Galluzzo M., Mazzone M., Giordano S., and Comoglio P.M. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 3 (2003) 347-361
20. 2 tension measurements. Cancer Res. 51 (1991) 6098-6102
21. Höckel M., Horn L.C., and Fritsch H. Association between the mesenchymal compartment of uterovaginal organogenesis and local tumour spread in stage IB-IIB cervical carcinoma: a prospective study. Lancet Oncol. 6 (2005) 751-756 [electronic publication 2005 Sep 2008]
22. Höckel M. Laterally extended endopelvic resection. Novel surgical treatment of locally recurrent cervical carcinoma involving the pelvic side wall. Gynecol. Oncol. 91 (2003) 369-377
23. Winter S.C., Shah K.A., Campo L., et al. Relation of erythropoietin and erythropoietin receptor expression to hypoxia and anemia in head and neck squamous cell carcinoma. Clin. Cancer Res. 11 (2005) 7614-7620
24. Cruz J., Reis-Filho J.S., Silva P., and Lopes J.M. Expression of c-met tyrosine kinase receptor is biologically and prognostically relevant for primary cutaneous malignant melanomas. Oncology 65 (2003) 72-82
25. O'Leary T.J. Standardization in immunohistochemistry. Appl. Immunohistochem. Mol. Morphol. 9 (2001) 3-8
26. Seidal T., Balaton A.J., and Battifora H. Interpretation and quantification of immunostains. Am. J. Surg. Pathol. 25 (2001) 1204-1207
27. Tsai H.W., Chow N.H., Lin C.P., Chan S.H., Chou C.Y., and Ho C.L. The significance of prohibitin and c-Met/hepatocyte growth factor receptor in the progression of cervical adenocarcinoma. Hum. Pathol. 37 (2006) 198-204 [electronic publication 2005 Dec 2020]
28. Gauthier P., Gore I., Shingleton H.M., Soong S.J., Orr Jr. J.W., and Hatch K.D. Identification of histopathologic risk groups in stage IB squamous cell carcinoma of the cervix. Obstet. Gynecol. 66 (1985) 569-574
29. Shinohara S., Ochi T., Miyazaki T., et al. Histopathological prognostic factors in patients with cervical cancer treated with radical hysterectomy and postoperative radiotherapy. Int. J. Clin. Oncol. 9 (2004) 503-509
30. Dery M.A., Michaud M.D., and Richard D.E. Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators. Int. J. Biochem. Cell Biol. 37 (2005) 535-540
31. Mayer A., Wree A., Hockel M., Leo C., Pilch H., and Vaupel P. Lack of correlation between expression of HIF-1alpha protein and oxygenation status in identical tissue areas of squamous cell carcinomas of the uterine cervix. Cancer Res. 64 (2004) 5876-5881
32. Airley R., Loncaster J., Davidson S., et al. Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix. Clin. Cancer Res. 7 (2001) 928-934
33. Swinson D.E., Jones J.L., Richardson D., et al. Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer. J. Clin. Oncol. 21 (2003) 473-482
34. Denko N., Schindler C., Koong A., Laderoute K., Green C., and Giaccia A. Epigenetic regulation of gene expression in cervical cancer cells by the tumor microenvironment. Clin. Cancer Res. 6 (2000) 480-487
35. Ghafar M.A., Anastasiadis A.G., Chen M.W., et al. Acute hypoxia increases the aggressive characteristics and survival properties of prostate cancer cells. Prostate 54 (2003) 58-67
36. Lund E.L., Hog A., Olsen M.W., Hansen L.T., Engelholm S.A., and Kristjansen P.E. Differential regulation of VEGF, HIF1alpha and angiopoietin-1, -2 and -4 by hypoxia and ionizing radiation in human glioblastoma. Int. J. Cancer 108 (2004) 833-838